Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

Connecticut · 2026 Regular Session · Bill

SB 451: AN ACT ESTABLISHING AN ADVISORY COUNCIL ON CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY AND OTHER GENE THERAPIES.

In committee Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

SB 451 is a bill introduced in the Connecticut Senate on March 5, 2026. According to its official title, it concerns: AN ACT ESTABLISHING AN ADVISORY COUNCIL ON CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY AND OTHER GENE THERAPIES. Primary sponsor: Martha Marx (Democratic/Working Families). Most recent recorded action (April 9, 2026): FILE NO. 566.

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Sponsors

Sponsors by party (alphabetical): Democratic/Working Families 1

NameRolePartyChamberDistrict
Martha MarxPrimary sponsorDemocratic/Working FamiliesSenate20

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. FILE NO. 566
  2. SENATE CALENDAR NUMBER 332
  3. FAV. RPT., TAB. FOR CAL., SEN.
  4. RPTD. OUT OF LCO
  5. REFERRED TO Office of Legislative Research AND Office of Fiscal Analysis 04/08/26
  6. FILED WITH LCO
  7. Joint Favorable
  8. PUBLIC HEARING 0313
  9. REF. TO JOINT COMM. ON Public Health

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source